Vera Therapeutics

Human kidney anatomy
Pharma

Vera’s dual-target atacicept wins FDA approval for IgAN

While atacicept is the first BAFF/APRIL dual inhibitor to enter the U.S. market, Vertex's povetacicept is trailing closely.
Angus Liu Jul 7, 2026 12:23pm
space launch rocketship

Top 10 most anticipated drug launches of 2026

Feb 2, 2026 3:00am